Clinical trials
Recruiting Phase 1/2 Mesothelioma, Malignant trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Antwerp | 2 |
| 7 Hills Pharma, LLC | 1 |
| A2 Biotherapeutics Inc. | 1 |
| Beijing Biotech | 1 |
| Cancer Research UK | 1 |
| InSilico Medicine Hong Kong Limited | 1 |
| Medicenna Therapeutics, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Portage Biotech | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 10 |
| Colorectal Neoplasms | 4 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Neoplasm Metastasis | 3 |
| Endometrial Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Kidney Neoplasms | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.